TrialJAMA oncology2020

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.

Wendy A Woodward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.